HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

HIMS

Hims & Hers Health, Inc. (Russell 2000)

Healthcare — Drug Manufacturers - Specialty & Generic

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. The company was formerly known as Hims, Inc. and changed its name to Hims & Hers Health, Inc. in January 2021. The company was founded in 2017 and is based in San Francisco, California.

Hold 2.8 / 5 13 analysts
$29.30
$-0.49 (-1.64%)
Target: $31.15 (6.3%)

Price History

52-Week Range
Sign in to add HIMS to a watchlist or set price alerts.

Fundamentals

Market Cap$6.84B
P/E Ratio (TTM)-
Forward P/E39.74
EPS (TTM)$-0.64
Dividend Yield-
Profit Margin-5.51%
Revenue Growth38.20%
ROE-32.03%
Debt/Equity477.13
Recommendation Hold 2.8
Analyst Target$31.15
Analysts13
Next Earnings Aug 10, 2026 AMC
Indexes Russell 2000

Technical Indicators

RSI (14)58.6
Beta2.41
SMA 20$28.53
SMA 40$29.34
52-Week High$65.30
52-Week Low$13.74
50-Day Avg$29.42
200-Day Avg$27.62
Avg Volume$12.38M
Volume$7.90M

Performance Analysis

BULLISH

HIMS shows predominantly bullish signals based on its fundamentals and technicals.

~ Trading at 30% of its 52-week range.
+ RSI at 58.6 shows positive momentum.
~ Price dropped below the 50-day average but remains above the 200-day — possible short-term weakness.
+ Strong revenue growth of 38.2% year-over-year.
- Operating at a loss with -5.5% margin.
~ Wall Street consensus is "Hold" from 13 analysts.
+ Average analyst target of $31.15 implies 6.3% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Oct 01, 2026 21:01 UTC

Back to Screener Export Report